Viewing Study NCT01046916


Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2026-02-22 @ 3:56 PM
Study NCT ID: NCT01046916
Status: COMPLETED
Last Update Posted: 2016-04-04
First Post: 2010-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module